Cargando…
Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor
Studies suggest that ovarian hyperstimulation syndrome (OHSS) can be treated by reducing the level of vascular endothelial growth factor (VEGF). However, due to the side effects of commercially available VEGF-reducing drugs, they can be ruled out as a suitable treatment for OHSS; therefore, research...
Autores principales: | Tahermanesh, Kobra, Hakimpour, Sahar, Govahi, Azam, Keyhanfar, Fariborz, Kashi, Abolfazl Mehdizadeh, Chaichian, Shahla, Shahriyaripour, Roya, Ajdary, Marziyeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797301/ https://www.ncbi.nlm.nih.gov/pubmed/36588534 http://dx.doi.org/10.1155/2022/1111777 |
Ejemplares similares
-
The effect of diluted ropivacaine in distending fluid on cramping pain after hysteroscopic surgeries: a randomized clinical trial study
por: Tahermanesh, Kobra, et al.
Publicado: (2022) -
Does laparoscopic treatment of deep endometriosis improve sexual dysfunction
por: Mehdizadehkashi, Abolfazl, et al.
Publicado: (2023) -
Right-side inguinal canal endometriosis at ultrasound: A case report
por: Mehdizadeh, Abolfazl, et al.
Publicado: (2022) -
Effect of PLGA Nanoparticle-Mediated Delivery of miRNA 503 on
The Apoptosis of Ovarian Endometriosis Cells
por: Chaichian, Shahla, et al.
Publicado: (2022) -
Interaction of sperm with endometrium can regulate genes involved in endometrial receptivity pathway in mice: An experimental study
por: Ajdary, Marziyeh, et al.
Publicado: (2020)